HomeYDO1 • FRA
add
Madrigal Pharmaceuticals Inc
Previous close
€310.90
Day range
€305.20 - €311.90
Year range
€175.50 - €349.20
Market cap
7.44B USD
Avg Volume
9.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 103.32M | — |
Operating expense | 166.87M | 42.41% |
Net income | -59.42M | 47.04% |
Net profit margin | -57.51 | — |
Earnings per share | -2.71 | 52.29% |
EBITDA | -66.63M | 43.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 926.25M | 46.07% |
Total assets | 1.04B | 62.71% |
Total liabilities | 287.86M | 22.38% |
Total equity | 754.38M | — |
Shares outstanding | 22.08M | — |
Price to book | 9.07 | — |
Return on assets | -15.83% | — |
Return on capital | -18.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -59.42M | 47.04% |
Cash from operations | -104.49M | -30.72% |
Cash from investing | -47.95M | 86.76% |
Cash from financing | 19.77M | -95.88% |
Net change in cash | -132.66M | -450.41% |
Free cash flow | -76.05M | -80.34% |
About
Founded
2011
Headquarters
Website
Employees
528
